Evidence map›Paper›PMID 30729227›Full record

ArticleACS omega2019

Multiplex Viral Detection Platform Based on a Aptamers-Integrated Microfluidic Channel.

Nileshi Saraf, Michael Villegas, Bradley Jay Willenberg, Sudipta Seal

Abstract read
In one paragraph

Article in ACS omega, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Aptamer-based biosensors for virus protein detection.Trends in analytical chemistry : TRAC · 2022
    Review
  6. Article
  7. Aptamers isolated against mosquito-borne pathogens.World journal of microbiology & biotechnology · 2021
    Review
  8. Aptamer Applications in Emerging Viral Diseases.Pharmaceuticals (Basel, Switzerland) · 2021
    Review
  9. Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nileshi SarafAdvanced Materials Processing and Analysis Centre, Department of Materials Science and Engineering, Department of Internal Medicine, College of Medicine, and Nanoscience Technology Centre, University of Central Florida, Orlando, Florida 32827, United States.
Michael VillegasUniversity of Florida, Gainesville, Florida 32611, United States.
Bradley Jay WillenbergAdvanced Materials Processing and Analysis Centre, Department of Materials Science and Engineering, Department of Internal Medicine, College of Medicine, and Nanoscience Technology Centre, University of Central Florida, Orlando, Florida 32827, United States.
Sudipta SealAdvanced Materials Processing and Analysis Centre, Department of Materials Science and Engineering, Department of Internal Medicine, College of Medicine, and Nanoscience Technology Centre, University of Central Florida, Orlando, Florida 32827, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A polydimethylsiloxane-based microfluidic device has been developed for the multiplex detection of viral envelope proteins such as Zika and chikungunya on a single platform using aptamer-analyte interactions. The channel is integrated with microsized pillars that increase the surface area allowing more aptamers to attach to the incoming envelope protein molecules, thus increasing the overall sensitivity of the system. The working of the device depends on the formation of protein-mediated sandwich morphology that is obtained using an aptamer and aptamer-functionalized gold nanoparticle (AuNP) pair. The colorimetric signal is obtained upon introduction of silver reagents into the channel, which are selectively deposited on the AuNP surface, providing a gray contrast in the testing zone. The microfluidic channel approach successfully detected clinically relevant concentrations of Zika and chikungunya envelope proteins in phosphine-buffered saline (1 pM) and calf blood (100 pM) with high specificity using gold-decorated aptamers integrated in a microfluidic channel.

Identifiers

PMID30729227
PMCPMC6358057

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.